Stanley Druckenmiller's TWST Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 206,000 shares of Twist Bioscience Corporation (TWST) worth $9.79 M, representing 0.29% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Stanley Druckenmiller has initiated a new position in TWST, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Twist Bioscience Corporation (TWST) Holding Value Over Time
Track share changes against reported price movement
Quarterly Twist Bioscience Corporation (TWST) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +206,000 | New Buy | 206,000 | $47.52 |
Stanley Druckenmiller's Twist Bioscience Corporation Investment FAQs
Stanley Druckenmiller first purchased Twist Bioscience Corporation (TWST) in Q1 2026, acquiring 206,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Twist Bioscience Corporation (TWST) for 1 quarters since Q1 2026.
Stanley Druckenmiller's largest addition to Twist Bioscience Corporation (TWST) was in Q1 2026, adding 206,000 shares worth $9.79 M.
According to the latest 13F filing for Q1 2026, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 206,000 shares of Twist Bioscience Corporation (TWST), valued at approximately $9.79 M.
As of the Q1 2026 filing, Twist Bioscience Corporation (TWST) represents approximately 0.29% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Twist Bioscience Corporation (TWST) was 206,000 shares, as reported at the end of Q1 2026.